MARTINGALE ASSET MANAGEMENT L P - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARTINGALE ASSET MANAGEMENT L P ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$144,000
-16.8%
19,1530.0%0.00%0.0%
Q3 2021$173,000
-19.5%
19,153
+6.7%
0.00%0.0%
Q2 2021$215,000
+76.2%
17,953
-5.8%
0.00%0.0%
Q1 2020$122,000
-71.4%
19,050
-62.5%
0.00%
-50.0%
Q4 2019$426,000
-4.3%
50,850
+3.5%
0.00%
-20.0%
Q3 2019$445,000
+8.3%
49,150
+28.8%
0.01%
+25.0%
Q2 2019$411,00038,1490.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders